Optimization of ultrasound-mediated drug delivery to the brain under clinically relevant conditions
在临床相关条件下优化超声介导的药物递送至大脑
基本信息
- 批准号:10701788
- 负责人:
- 金额:$ 49.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-12 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AcousticsAdverse eventAnimal ExperimentsAnimalsBackBlood - brain barrier anatomyBlood VesselsBrainBrain NeoplasmsCalibrationCarboplatinCell LineCentral Nervous SystemCentral Nervous System DiseasesCephalicClinicClinicalClinical TreatmentClinical TrialsContrast MediaDiseaseDisease modelDoseDrug Delivery SystemsElectronicsFocused UltrasoundFutureGlioblastomaGliomaGoalsGrowthHumanInfiltrationLearningLong-Term EffectsMediatingMethodsMicrobubblesModelingMonitorMotivationMusNeurodegenerative DisordersNoiseNude RatsPatientsPharmaceutical PreparationsPre-Clinical ModelProceduresPropertyProtocols documentationRattusResearchSafetySamplingSeriesSignal TransductionSonicationStructureSystemTechnologyTherapeuticTherapeutic AgentsTissuesTumor BurdenValidationVariantVisitWorkattenuationbench to bedsideblood-brain barrier disruptionclinically relevantcraniumdetectorearly experienceeffective therapyexperienceexperimental studyhistological studiesimprovedimproved outcomenonhuman primatepatient derived xenograft modelpre-clinicalpreclinical studypreventsimulationsuccesstooltreatment planningtumorultrasoundwhite matter
项目摘要
Summary
The blood-brain barrier prevents most drugs from reaching the central nervous system and is one of the biggest
problems in developing new effective therapies for patients with brain tumors, neurodegenerative diseases, and
other disorders. The use of ultrasound in combination with injected microbubble agents has emerged as a prom-
ising method to temporarily disrupt the barrier. After over a decade of preclinical studies in animals, multiple
commercial systems have been developed and clinical trials have begun. Early experience with these trials have
shown several problems that were predicted by the preclinical work. The clinical treatments use lower doses of
microbubbles, have to overcome the variable attenuation of the human skull, and are often in white matter. As a
result, treatments have been suboptimal. The purpose of this proposal is to provide a roadmap to clinical success
for ultrasound-mediated blood-brain barrier opening. We will develop new treatment planning methods that ac-
count for the human skull, electronic steering of the focused ultrasound beam, and variations in microbubble
concentrations in different tissue structures. These methods will be employed to improve safety and control of
the procedure. Next, we will investigate whether we can improve our ability to control the procedure in white
matter targets and evaluate the safety of repeated blood-brain barrier disruption in white matter targets. Finally,
using what we have learned, we will investigate whether we can deliver sufficient drugs to treat a highly infiltrating
tumor model. If successful, this work could have a significant impact on future use of this exciting technology.
概括
血脑屏障可以阻止大多数药物进入中枢神经系统,并且是最大的药物之一
针对患有脑肿瘤患者,神经退行性疾病和
其他疾病。超声使用与注入的微泡剂的结合已成为一种舞会
临时破坏障碍的方法。在动物中进行了十多年的临床前研究之后,多个
已经开发了商业系统,并开始临床试验。这些试验的早期经验有
显示了临床前工作预测的几个问题。临床治疗使用较低剂量
微泡,必须克服人颅骨的可变衰减,并且通常在白质中。作为
结果,治疗次优。该建议的目的是为临床成功提供路线图
用于超声介导的血脑屏障开口。我们将开发新的治疗计划方法
计数人头骨,聚焦超声梁的电子转向以及微泡中的变化
不同组织结构中的浓度。这些方法将用于提高安全性和控制
过程。接下来,我们将调查我们是否可以提高控制白色程序的能力
物质目标并评估白质目标中反复的血脑屏障破坏的安全性。最后,
使用我们学到的知识,我们将调查是否可以提供足够的药物来治疗高度浸润
肿瘤模型。如果成功,这项工作可能会对这种令人兴奋的技术的未来使用产生重大影响。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nonspherical ultrasound microbubbles.
- DOI:10.1073/pnas.2218847120
- 发表时间:2023-03-28
- 期刊:
- 影响因子:11.1
- 作者:Dasgupta, Anshuman;Sun, Tao;Palomba, Roberto;Rama, Elena;Zhang, Yongzhi;Power, Chanikarn;Moeckel, Diana;Liu, Mengjiao;Sarode, Apoorva;Weiler, Marek;Motta, Alessandro;Porte, Celine;Magnuska, Zuzanna;Elshafei, Asmaa Said;Barmin, Roman;Graham, Adam;McClelland, Arthur;Rommel, Dirk;Stickeler, Elmar;Kiessling, Fabian;Pallares, Roger M.;De Laporte, Laura;Decuzzi, Paolo;McDannold, Nathan;Mitragotri, Samir;Lammers, Twan
- 通讯作者:Lammers, Twan
Transferrin Receptor-Targeted Nonspherical Microbubbles for Blood-Brain Barrier Sonopermeation.
用于血脑屏障超声渗透的转铁蛋白受体靶向非球形微泡。
- DOI:10.1002/adma.202308150
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Dasgupta,Anshuman;Sun,Tao;Rama,Elena;Motta,Alessandro;Zhang,Yongzhi;Power,Chanikarn;Moeckel,Diana;Fletcher,Stecia-Marie;Moosavifar,Mirjavad;Barmin,Roman;Porte,Céline;Buhl,EvaMiriam;Bastard,Céline;Pallares,RogerM;Kiessling,Fa
- 通讯作者:Kiessling,Fa
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nathan J. McDannold其他文献
Nathan J. McDannold的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nathan J. McDannold', 18)}}的其他基金
Noninvasive monitoring of brain tumor development with focused ultrasound and extracellular vesicles
利用聚焦超声和细胞外囊泡无创监测脑肿瘤的发展
- 批准号:
10159901 - 财政年份:2019
- 资助金额:
$ 49.45万 - 项目类别:
Noninvasive monitoring of brain tumor development with focused ultrasound andextracellular vesicles
利用聚焦超声和细胞外囊泡无创监测脑肿瘤的发展
- 批准号:
10400118 - 财政年份:2019
- 资助金额:
$ 49.45万 - 项目类别:
MRI-guided focused ultrasound for drug delivery and ablation of brain tumors
MRI 引导聚焦超声用于药物输送和脑肿瘤消融
- 批准号:
9313802 - 财政年份:2013
- 资助金额:
$ 49.45万 - 项目类别:
MRI-guided focused ultrasound for drug delivery and ablation of brain tumors
MRI 引导聚焦超声用于药物输送和脑肿瘤消融
- 批准号:
9102026 - 财政年份:2013
- 资助金额:
$ 49.45万 - 项目类别:
Technology for controlling ultrasound targeted drug delivery in brain
控制脑内超声靶向药物输送的技术
- 批准号:
8506193 - 财政年份:2013
- 资助金额:
$ 49.45万 - 项目类别:
MRI-guided focused ultrasound for drug delivery and ablation of brain tumors
MRI 引导聚焦超声用于药物输送和脑肿瘤消融
- 批准号:
8672612 - 财政年份:2013
- 资助金额:
$ 49.45万 - 项目类别:
BLOOD BRAIN BARRIER DISRUPTION USING FOCUSED ULTRASOUND IN LARGE ANIMAL MODELS
在大型动物模型中使用聚焦超声破坏血脑屏障
- 批准号:
8358016 - 财政年份:2011
- 资助金额:
$ 49.45万 - 项目类别:
Blood-Brain Barrier Disruption using Focused Ultrasound in a Large Animal Model
在大型动物模型中使用聚焦超声破坏血脑屏障
- 批准号:
7852751 - 财政年份:2009
- 资助金额:
$ 49.45万 - 项目类别:
NOVEL MRI CONTRAST AGENT FOR MONITORING THERMAL ABLATION
用于监测热消融的新型 MRI 造影剂
- 批准号:
7960871 - 财政年份:2009
- 资助金额:
$ 49.45万 - 项目类别:
相似海外基金
Water-based liquid embolic agent for the treatment of vascular rich tumors
用于治疗富含血管肿瘤的水基液体栓塞剂
- 批准号:
10766633 - 财政年份:2023
- 资助金额:
$ 49.45万 - 项目类别:
Signaling pathways regulating mechanoreflex sensitization in cardiovascular disease
调节心血管疾病中机械感受反射敏化的信号通路
- 批准号:
10641947 - 财政年份:2022
- 资助金额:
$ 49.45万 - 项目类别:
Repurposing Siponimod for Alzheimer's Disease
重新利用西波尼莫德治疗阿尔茨海默病
- 批准号:
10671526 - 财政年份:2021
- 资助金额:
$ 49.45万 - 项目类别:
Repurposing Siponimod for Alzheimer's Disease
重新利用西波尼莫德治疗阿尔茨海默病
- 批准号:
10274977 - 财政年份:2021
- 资助金额:
$ 49.45万 - 项目类别:
Repurposing Siponimod for Alzheimer's Disease
重新利用西波尼莫德治疗阿尔茨海默病
- 批准号:
10587745 - 财政年份:2021
- 资助金额:
$ 49.45万 - 项目类别: